Search Results
Leveraging evolutionary trade-offs and phage selection pressure to reduce bacterial pathogenicity
[Paul Turner] Leveraging evolutionary trade-offs and phage selection pressure to reduce bacterial pa
Club EvMed: Can evolution-thinking bring phage therapy closer to standard-of-care?
The Broad-Reaching Impacts of Bacteriophage Viruses: Bacterial Evolution, Microbiomes, Human Health
Paul E. Turner (Yale) 2: Virus Adaptation to Environmental Change
Prof. Paul Turner of Yale University on Phage Therapy
2021 Friday Evening Lecture with Paul Turner
Barbara Natterson-Horowitz and colleagues | The future of evolutionary medicine
APF #1: Understanding the basics of phage therapy research with Dr. Paul Turner
Plasmids as breeding ground and vehicles for beta-lactamases. ▸ Paul Turner (Yale)
Julia Terrell TCRSF Submission | Efficacy of bacteriophage therapy during the perinatal period
Viruses to the rescue : The fight against superbugs.
![[Paul Turner] Leveraging evolutionary trade-offs and phage selection pressure to reduce bacterial pa](https://img.youtube.com/vi/cceE3esSD2I/hqdefault.jpg)
